Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
May 8, 2000
Conformational mapping of the N-terminal segment of surfactant protein B in lipid using 13C-enhanced Fourier transform infrared spectroscopy
L M Gordon, K Y Lee, M M Lipp, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
June 4, 2004
A theta-defensin composed exclusively of D-amino acids is active against HIV-1
S M Owen, D Rudolph, W Wang, et al.
Biochimica Et Biophysica Acta
|
August 2, 2001
Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium
I H Lee, Y S Lee, C H Kim, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
December 1, 2005
The role of charged amphipathic helices in the structure and function of surfactant protein B
A J Waring, F J Walther, L M Gordon, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 8, 2025
[Results of a 5-year project for the early diagnosis of multiple sclerosis in first-line blood relatives (RADIRS program)]
A N Boyko, V V Gosteva, M A Omarova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
October 5, 2023
[Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population]
S A Sivertseva, A M Prilenskaya, E V Popova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
September 11, 2015
[Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial]
S A Rumyantsevа, A L Kovalenko, E V Silinа, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 16, 2017
[A comparative placebo-controlled clinical study on the efficacy and safety of interferon beta-1a for subcutaneous injections in patients with remitting multiple sclerosis: results of the first year of observations]
A N Boyko, L P Bosenko, V V Vasilovskiy, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 4, 2019
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a]
A N Boyko, L P Bosenko, V V Vasilovskiy, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
May 8, 2000
Conformational mapping of the N-terminal segment of surfactant protein B in lipid using 13C-enhanced Fourier transform infrared spectroscopy
L M Gordon, K Y Lee, M M Lipp, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
June 4, 2004
A theta-defensin composed exclusively of D-amino acids is active against HIV-1
S M Owen, D Rudolph, W Wang, et al.
Biochimica Et Biophysica Acta
|
August 2, 2001
Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium
I H Lee, Y S Lee, C H Kim, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
December 1, 2005
The role of charged amphipathic helices in the structure and function of surfactant protein B
A J Waring, F J Walther, L M Gordon, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 8, 2025
[Results of a 5-year project for the early diagnosis of multiple sclerosis in first-line blood relatives (RADIRS program)]
A N Boyko, V V Gosteva, M A Omarova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
October 5, 2023
[Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population]
S A Sivertseva, A M Prilenskaya, E V Popova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
September 11, 2015
[Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial]
S A Rumyantsevа, A L Kovalenko, E V Silinа, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 16, 2017
[A comparative placebo-controlled clinical study on the efficacy and safety of interferon beta-1a for subcutaneous injections in patients with remitting multiple sclerosis: results of the first year of observations]
A N Boyko, L P Bosenko, V V Vasilovskiy, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 4, 2019
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a]
A N Boyko, L P Bosenko, V V Vasilovskiy, et al.
Page
of 6